Listed

Celldex Therapeutics, Inc.

CLDXNasdaqCIK 744218HealthcareFiscal year ends Dec 31

Reports and events: 261 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Celldex Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2019-03-0716:11 ET10-KAnnual reportPeriod 2018-12-310001047469-19-000992
2019-03-0716:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-19-001578
2019-02-0811:49 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001104659-19-006667
2018-12-1016:01 ET8-K5.02 Departure or appointment of officers or directors0001104659-18-072097
2018-11-2709:18 ET8-K3.01 Delisting notice0001104659-18-070024
2018-11-0716:07 ET10-QQuarterly reportPeriod 2018-09-300001104659-18-066648
2018-11-0716:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-18-007706
2018-08-0816:06 ET10-QQuarterly reportPeriod 2018-06-300001104659-18-050496
2018-08-0816:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-18-005867
2018-06-1416:01 ET8-K5.07 Shareholder vote results0001104659-18-040165
2018-06-0108:00 ET8-K3.01 Delisting notice0001104659-18-037447
2018-05-1008:19 ET10-QQuarterly reportPeriod 2018-03-310001104659-18-031972
2018-05-1008:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-18-003787
2018-04-3009:00 ETDEF 14AProxy statementPeriod 2018-06-130001047469-18-003326
2018-04-2416:01 ET8-K2.05 Exit or disposal costs0001104659-18-026170
2018-04-1607:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-18-002723
2018-03-0716:11 ET10-KAnnual reportPeriod 2017-12-310001047469-18-001363
2018-03-0716:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-18-001754
2017-12-2907:30 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-17-075519
2017-11-0916:26 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-17-067404
2017-11-0708:22 ET10-QQuarterly reportPeriod 2017-09-300001104659-17-066472
2017-11-0708:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-17-006680
2017-10-0308:09 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-17-060390
2017-09-1216:05 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-17-056738
2017-08-0816:06 ET10-QQuarterly reportPeriod 2017-06-300001104659-17-050250
2017-08-0816:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-17-004841
2017-07-0516:01 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-17-043557
2017-06-1608:58 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001104659-17-039747
2017-05-0916:06 ET10-QQuarterly reportPeriod 2017-03-310001104659-17-031139
2017-05-0916:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-17-002857
2017-04-2816:11 ETDEF 14AProxy statementPeriod 2017-06-150001047469-17-003056
2017-03-1416:23 ET10-KAnnual reportPeriod 2016-12-310001047469-17-001564
2017-03-1416:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-17-001503
2017-03-0116:03 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-17-013035
2017-02-0716:02 ET8-K/A2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0001104659-17-006973
2016-12-1416:07 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-16-162070
2016-12-0516:03 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-16-160632
2016-11-2916:04 ET8-K2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-16-159586
2016-11-0716:16 ET10-QQuarterly reportPeriod 2016-09-300001104659-16-155185
2016-11-0716:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-16-013004
2016-11-0116:07 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-16-153723
2016-08-1108:02 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-16-138856
2016-08-0816:11 ET10-QQuarterly reportPeriod 2016-06-300001104659-16-137913
2016-08-0816:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-16-011578
2016-06-0910:37 ET8-K5.07 Shareholder vote results0001104659-16-126316
2016-05-1916:04 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-16-122085
2016-05-0508:43 ET10-QQuarterly reportPeriod 2016-03-310001104659-16-118017
2016-05-0508:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-16-009727
2016-04-2108:03 ETDEF 14AProxy statementPeriod 2016-06-080001047469-16-012401
2016-03-0707:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-008396

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 19:04 ET. Listed shows no prices and gives no investment advice.